KROS

SetupConviction 37LongHealthcareScan · Fri, Oct 2, 2026

Ascending triangletriangle

Keros Therapeutics, Inc. (KROS) closed at $11.36 (+0.89%) on Oct 2, 2026. It is in the "Setting up" lane with a ascending triangle pattern. Price is above its 50-day and below its 200-day moving average. RSI(14) 53, RS Rating 44, -47.9% from its 52-week high, -38.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

KROS$11.36+0.89%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 203.5K

Jul 7Jul 23Aug 11Aug 27Sep 16Oct 2

Trade plan

LongReward : Risk0.76

Entry

11.42

Risk

Stop

10.94

-4.3% to stop

Reward

Target 1

11.79

+3.3% to target

Stretch

Target 2

12.16

+6.5% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Keros Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.kerostx.com ↗

Price11.36

Change+0.89%

Gap-0.44%

Rel volume—

Avg volume190.1K

Avg $ vol2.15M

SMA 2011.31

SMA 5010.94

SMA 20012.92

Price vs 50+4.06%

Price vs 200-11.93%

MA stackmixed

50/200 cross—

Supertrendup · 10.29

RSI (14)53

MACD hist-0.03

MACD crossbear · 3d

Stoch %K / %D50 / 48

ADX (14)20

+DI / −DI19 / 17

RSI divergence—

MACD divergence—

ATR %4.11%

ADR %3.78%

52w high21.84

52w low9.91

From 52w high-47.89%

Above 52w low+14.83%

New 52w highNo

SqueezeOn · 22d

Bollinger width7.73%

%B0.58

Donchian pos50.37%

Donchian high12.05

Donchian low10.70

AVWAP (52w high)13.77

vs AVWAP high-17.37%

AVWAP (52w low)10.86

vs AVWAP low+4.80%

OBV trendFlat

Chaikin MF (20)0.18

Today vs 20d—

Avg vol (14d)204.29K

Avg vol (20d)190.1K

Avg $ vol (20d)2.15M

Market cap225.63M

RS Rating44 / 99

RS 3m (vs SPY)+0.73%

RS 6m (vs SPY)-22.52%

RS line new highNo

Trend template2/8

Technical rank56.2

1 week-2.07%

1 month+1.34%

3 months+3.17%

6 months-5.17%

1 year-25.52%

YTD-38.62%

P/E2.59

P/B0.86

P/S0.92

P/FCF2.13

EPS2.30

Div yield—

ROE33.17%

ROA30.26%

Debt/Eq—

Current21.96

EV/EBITDA—

Gross margin—

Net margin35.65%

Rev growth—

EPS growth146.44%

Price target18.80

Target upside65.20%

Analyst ratingBuy

Institutional102.34%

Ent. value-31.97M

Revenue0

Net income-28.71M

Gross profit—

Free cash flow105.95M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out19.79M

Employees87

ListedWed, Apr 8, 2020

Free float18.42M

Float %93.1%

Short interest1.17M

Days to cover6.1d

Short volume66.4%

Squeeze score55 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.45 vs −$1.25

Last surprise-16.0% miss

Setup gradeD

Conviction37 / 100

Pattern quality48%

Tech rank56.2 / 100

Group rank14 / 100

Status laneSetting up

Setup directionLong

Pattern familyTriangle

Resistance11.42

Support11.05

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KROS

All disclosures →

No recent disclosed trades by Congress in KROS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KROS · open-market 3 buys · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Cho Esther Chief Legal Officer · Common Stock · 2026-08-18	Sell	4.49K	$46K	2026-08-18	2026-08-20
Newton Charles W. Director · Common Stock · 2026-08-18	Sell	551	$6K	2026-08-18	2026-08-20
Lerner Lorena Raquel Chief Scientific Officer · Common Stock · 2026-08-18	Sell	3.57K	$37K	2026-08-18	2026-08-20
Tanini Annita Corp. Controller & VP, Finance · Common Stock · 2026-08-18	Sell	1.22K	$13K	2026-08-18	2026-08-20
BIENAIME JEAN JACQUES Director · Common Stock · 2026-08-17	Buy	1K	$10K	2026-08-17	2026-08-19
BIENAIME JEAN JACQUES Director · Common Stock · 2026-07-15	Buy	1K	$11K	2026-07-15	2026-07-17
BIENAIME JEAN JACQUES Director · Common Stock · 2026-06-15	Buy	1K	$10K	2026-06-15	2026-06-17
Knowles Julius Director · Common Stock · 2026-06-04	Sell	2.63K	$28K	2026-06-04	2026-06-08
Farzan Nima Director · Common Stock · 2026-06-04	Sell	2.63K	$28K	2026-06-04	2026-06-08
Knowles Julius Director · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-08

SEC filings

EDGAR filings in KROS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

KROS

Trade plan

Recent news

Get daily signals & real-time alerts.